MVA-A85A vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MVA-A85A vaccine, covering 2007-01-18 to 2007-01-18. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers. [Phase 1]